{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:52:17Z","timestamp":1763139137743,"version":"3.38.0"},"reference-count":61,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lab Anim"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:p> The chemotherapeutic streptozotocin is used for induction of diabetes in animal models including non-human primates. Being a cytotoxic nitrosourea compound, it can be associated with adverse events (AEs), mainly nausea and emesis, nephrotoxicity, elevated liver transaminase levels, pulmonary oedema and, most prominently, metabolic acidosis: these can be severe in some cases. The incidence and gravity are to some extent related to the characteristics of the individual animal, diagnostic tools, prompt recognition of symptoms and supportive measures. Careful animal selection, dose adaptation and supportive actions such as renal protective hydration are the main tools in managing AEs, but do not fully eliminate unavoidable and sometimes life-threatening conditions. In our centre we have built experience in a cohort of 78 cynomolgus and rhesus macaques in which six cases manifested severe AEs (8%). This experience has prompted implementation of strategies for early detection and management of adverse effects, together with an animal refinement programme. We present here specific pretreatment regimens, post-infusion laboratory evaluations, and flow charts to assess\/treat metabolic acidosis and precipitating factors. Case reports of the six animals with severe AEs are presented to illustrate management of AEs, especially metabolic acidosis, and criteria for early euthanasia where appropriate. We conclude that improved monitoring and validated tools allow for optimal management of adverse effects in an early stage of their manifestation. Reduced morbidity and mortality not only improve individual animal wellbeing but also avoid model-induced confounding that diminishes the translational value of the experimental protocol. <\/jats:p>","DOI":"10.1258\/la.2012.011077","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T02:17:11Z","timestamp":1336702631000},"page":"178-192","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":12,"title":["Management of adverse side-effects after chemotherapy in macaques as exemplified by streptozotocin: case studies and recommendations"],"prefix":"10.1177","volume":"46","author":[{"given":"Melanie L","family":"Graham","sequence":"first","affiliation":[{"name":"Schulze Diabetes Institute, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas A","family":"Mutch","sequence":"additional","affiliation":[{"name":"Schulze Diabetes Institute, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica A","family":"Kittredge","sequence":"additional","affiliation":[{"name":"Schulze Diabetes Institute, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric F","family":"Rieke","sequence":"additional","affiliation":[{"name":"Schulze Diabetes Institute, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas A","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, St Paul, MN 55108, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth K","family":"Zolondek","sequence":"additional","affiliation":[{"name":"Schulze Diabetes Institute, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron W","family":"Faig","sequence":"additional","affiliation":[{"name":"Schulze Diabetes Institute, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa A","family":"DuFour","sequence":"additional","affiliation":[{"name":"Schulze Diabetes Institute, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W","family":"Munson","sequence":"additional","affiliation":[{"name":"Schulze Diabetes Institute, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk-Jan","family":"Schuurman","sequence":"additional","affiliation":[{"name":"Schulze Diabetes Institute, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,7,1]]},"reference":[{"key":"bibr-LA-11-077C1","doi-asserted-by":"publisher","DOI":"10.1038\/244447a0"},{"key":"bibr-LA-11-077C2","first-page":"100","volume":"77","author":"Scharp DW","year":"1975","journal-title":"Surgery"},{"key":"bibr-LA-11-077C3","doi-asserted-by":"publisher","DOI":"10.1038\/ni0209-129"},{"key":"bibr-LA-11-077C4","unstructured":"DAIT, NIAID, NIH. Purified human pancreatic islets, in vivo islets function. Document No. 3104, A04, effective date 7 July 2008. See http:\/\/www.isletstudy.org\/CITDocs\/3104,%20A04%20In%20Vivo%20Islets%20Function.pdf (last checked 12 June 2011)"},{"key":"bibr-LA-11-077C5","doi-asserted-by":"publisher","DOI":"10.2337\/diab.31.1.S37"},{"key":"bibr-LA-11-077C6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddmod.2008.05.001"},{"key":"bibr-LA-11-077C7","doi-asserted-by":"publisher","DOI":"10.1038\/nm1369"},{"key":"bibr-LA-11-077C8","doi-asserted-by":"publisher","DOI":"10.3727\/000000006783982052"},{"key":"bibr-LA-11-077C9","doi-asserted-by":"publisher","DOI":"10.1258\/ebm.2011.011064"},{"key":"bibr-LA-11-077C10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1991.tb01958.x"},{"key":"bibr-LA-11-077C11","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199709000-00004"},{"key":"bibr-LA-11-077C12","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810915)48:6<1328::AID-CNCR2820480613>3.0.CO;2-N"},{"key":"bibr-LA-11-077C13","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197410)34:4<993::AID-CNCR2820340404>3.0.CO;2-T"},{"key":"bibr-LA-11-077C14","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.6-2-162"},{"key":"bibr-LA-11-077C15","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199908150-00003"},{"key":"bibr-LA-11-077C16","first-page":"172","volume":"48","author":"Litwak KN","year":"1998","journal-title":"Lab Anim Sci"},{"key":"bibr-LA-11-077C17","doi-asserted-by":"publisher","DOI":"10.2337\/diab.29.7.536"},{"key":"bibr-LA-11-077C18","doi-asserted-by":"publisher","DOI":"10.2337\/diab.19.2.85"},{"key":"bibr-LA-11-077C19","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199507000-00003"},{"key":"bibr-LA-11-077C20","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpa.0000235307.04110.a2"},{"journal-title":"J Med Primatol","year":"2011","author":"Graham ML","key":"bibr-LA-11-077C21"},{"key":"bibr-LA-11-077C22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0684.2008.00281.x"},{"key":"bibr-LA-11-077C23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0684.2009.00340.x"},{"key":"bibr-LA-11-077C24","first-page":"479","volume":"60","author":"Graham ML","year":"2010","journal-title":"Comp Med"},{"key":"bibr-LA-11-077C25","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2003.00047.x"},{"key":"bibr-LA-11-077C26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7092.1486a"},{"key":"bibr-LA-11-077C27","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4901"},{"key":"bibr-LA-11-077C28","doi-asserted-by":"publisher","DOI":"10.1097\/00075197-200107000-00002"},{"key":"bibr-LA-11-077C29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2008.10.014"},{"key":"bibr-LA-11-077C30","doi-asserted-by":"publisher","DOI":"10.1038\/laban0505-31"},{"key":"bibr-LA-11-077C31","first-page":"213","volume":"9","author":"Jen KL","year":"1985","journal-title":"Int J Obes"},{"key":"bibr-LA-11-077C32","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(02)02796-3"},{"key":"bibr-LA-11-077C33","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00040.x"},{"key":"bibr-LA-11-077C34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106180"},{"key":"bibr-LA-11-077C35","first-page":"195","volume":"12","author":"Wijkstrom M","year":"2003","journal-title":"Cell Transplant"},{"key":"bibr-LA-11-077C36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.2009.00543.x"},{"key":"bibr-LA-11-077C37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5810.2004.0053b.x"},{"key":"bibr-LA-11-077C38","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-007-0674-3"},{"key":"bibr-LA-11-077C39","first-page":"330","volume":"23","author":"Kerl ME","year":"2001","journal-title":"Compend Contin Educ Pract Vet"},{"key":"bibr-LA-11-077C40","first-page":"561","volume":"178","author":"Chastain CB","year":"1981","journal-title":"J Am Vet Med Assoc"},{"key":"bibr-LA-11-077C41","first-page":"392","volume-title":"Canine and Feline Endocrinology and Reproduction","author":"Feldman EC","year":"1996","edition":"2"},{"key":"bibr-LA-11-077C42","unstructured":"GrecoDS. Pancreatic disorders: diabetic ketoacidosis and insulinoma \u2013 treatment of DKA. In: WingfieldWE, RaffeMC, eds. The Veterinary ICU Book. Jackson, WY, USA: Teton NewMedia, 2002:846\u20138"},{"key":"bibr-LA-11-077C43","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.1.131"},{"key":"bibr-LA-11-077C44","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2006.8.671"},{"key":"bibr-LA-11-077C45","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8"},{"key":"bibr-LA-11-077C46","first-page":"1192","volume":"76","author":"Burge MR","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"bibr-LA-11-077C47","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-5616(95)50059-2"},{"key":"bibr-LA-11-077C48","doi-asserted-by":"publisher","DOI":"10.1136\/adc.83.6.514"},{"key":"bibr-LA-11-077C49","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.05.010"},{"key":"bibr-LA-11-077C50","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.8.1856"},{"key":"bibr-LA-11-077C51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvsm.2009.10.003"},{"key":"bibr-LA-11-077C52","doi-asserted-by":"publisher","DOI":"10.1007\/1-4020-2586-6_18"},{"key":"bibr-LA-11-077C53","unstructured":"HruskaKA, LeviM, SlatopolskyE. Disorders of phosphorus, calcium, and magnesium metabolism. In: SchrierRW, ed. Diseases of the Kidney and Urinary Tract. 8th edn. Philadelphia: Wolters Kluwer Health\/Lippincott Williams & Wilkins, 2007:2311"},{"key":"bibr-LA-11-077C54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1993.tb01018.x"},{"key":"bibr-LA-11-077C55","unstructured":"McBrydeKD, BunchmanTE. Continuous renal replacement therapy. In: WheelerDS, WongHR, ShanleyTP, eds. Pediatric Critical Care Medicine: Basic Science and Clinical Evidence. London: Springer, 2007:1235"},{"key":"bibr-LA-11-077C56","unstructured":"SafirsteinRL. Renal diseases induced by antineoplastic agents. In: SchrierRW, ed. Diseases of the Kidney and Urinary Tract. 8th edn. Philadelphia: Wolters Kluwer Health\/Lippincott Williams & Wilkins, 2007:1069\u201373"},{"volume-title":"Acute Kidney Disease. The Merck Veterinary Manual","year":"2011","author":"Merck Sharp &amp; Dohme Corp","key":"bibr-LA-11-077C57"},{"volume-title":"Diffuse Parenchymal Lung Disease","year":"2007","author":"Carnus P","key":"bibr-LA-11-077C58"},{"key":"bibr-LA-11-077C59","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-0689-4_10"},{"key":"bibr-LA-11-077C60","unstructured":"ShahabI, PattersonWP. Renal and electrolyte abnormalities due to chemotherapy. In: PerryMC, ed. The Chemotherapy Source Book. 4th edn. Philadelphia: Wolters Kluwer Health\/Lippincott Williams & Wilkins, 2008:223\u201333"},{"key":"bibr-LA-11-077C61","first-page":"866","volume":"171","author":"Bush M","year":"1977","journal-title":"J Am Vet Med Assoc"}],"container-title":["Laboratory Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/la.2012.011077","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1258\/la.2012.011077","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1258\/la.2012.011077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T04:45:52Z","timestamp":1740890752000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1258\/la.2012.011077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1258\/la.2012.011077"],"URL":"https:\/\/doi.org\/10.1258\/la.2012.011077","relation":{},"ISSN":["0023-6772","1758-1117"],"issn-type":[{"type":"print","value":"0023-6772"},{"type":"electronic","value":"1758-1117"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}